Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00596063 · ClinicalTrials.gov registry record · Phase 1
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.
A Phase 1 study, sponsored by Wockhardt.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00596063 is a Phase 1 study that has completed, run by Wockhardt. The registered enrollment target is 25 participants.
The verdict
NCT00596063, a Phase 1 study, has completed, sponsored by Wockhardt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is the comparative evaluation of the pharmacokinetics and pharmacodynamics of two recombinant regular human insulin injections administered subcutaneously in healthy volunteers under the conditions of euglycemic clamp.
Interventions
- BIOLOGICAL Wosulin R
- BIOLOGICAL Novolin R
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00596063
The ClinicalTrials.gov registry entry for NCT00596063 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wockhardt, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wosulin R is the first listed.
NCT00596063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00596063 about?
NCT00596063 is a clinical study titled "Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.". The purpose of this study is the comparative evaluation of the pharmacokinetics and pharmacodynamics of two recombinant regular human insulin injections administered subcutaneously in healthy volunteers under the conditions of euglycemic clamp.
What is the current status of trial NCT00596063?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2008-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00596063?
The interventions under investigation include: Wosulin R (BIOLOGICAL), Novolin R (BIOLOGICAL).
Who is sponsoring clinical trial NCT00596063?
This trial is sponsored by Wockhardt, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.